Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64K Buy
151
+104
+221% +$1.11K ﹤0.01% 1551
2026
Q1
$522 Sell
47
-49
-51% -$624 ﹤0.01% 1749
2025
Q4
$1.57K Hold
96
– – ﹤0.01% 1030
2025
Q3
$1.28K Hold
96
– – ﹤0.01% 1084
2025
Q2
$1.23K Buy
96
+47
+96% +$564 ﹤0.01% 1064
2025
Q1
$505 Buy
49
+7
+17% +$90 ﹤0.01% 1267
2024
Q4
$534 Hold
42
– – ﹤0.01% 1215
2024
Q3
$538 Hold
42
– – ﹤0.01% 1200
2024
Q2
$533 Buy
+42
New +$726 ﹤0.01% 1181

Other funds holding PATH

CVA Family Office's PATH Position: Q2 2026 in Review

CVA Family Office increased its UiPath (PATH) stake by 221% in Q2 2026, buying an estimated $1.11K and bringing the position to 151 shares worth $1.64K. The position accounts for ﹤0.01% of the portfolio, ranked #1551.

CVA Family Office first reported a position in PATH in Q2 2024 and has held it in 9 quarters since. 529 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • CVA Family Office held 151 shares of UiPath worth $1.64K as of Q2 2026.
  • CVA Family Office bought 104 UiPath shares in Q2 2026, an estimated $1.11K.
  • UiPath made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1551 holding.
  • CVA Family Office first reported a position in UiPath in Q2 2024 and has held it in 9 quarters since.
  • 529 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.